Titan Pharmaceuticals Announces Rigorous Sensitivity Analyses Confirm Effectiveness of Probuphine(R) for Opioid Dependence
Go back to Titan Pharmaceuticals Announces Rigorous Sensitivity Analyses Confirm Effectiveness of Probuphine(R) for Opioid Dependence| Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) | Delayed: 4.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.61 | 52 Week High | $8.74 | |||
| Open | $4.61 | 52 Week Low | $2.57 | |||
| Day High | $4.61 | P/E | 38.42 | |||
| Day Low | $4.61 | EPS | $0.12 | |||
| Volume | 179,941 | |||||
